b.
Interventions
| Comparison | Study, n | Patients, n | ||||
|---|---|---|---|---|---|---|
| MTX | 4 | 1,126 | ||||
| Tofacitinib 5 mg | 1 | 373 | ||||
| Baricitinib 4 mg | 1 | 159 | ||||
| Upadacitinib 15 mg | 1 | 317 | ||||
| Filgotinib 200 mg | 1 | 210 |
MTX, methotrexate; csDMARD, conventional synthetic disease-modifying antirheumatic disease; mTSS, modified total Sharp score.
DAS28-CRP < 2.6: Disease Activity Score in 28 joints using the C-reactive protein level.
DAS28-CRP ≤ 3.2.
DAS28-ESR < 2.6: DAS28 using the erythrocyte sedimentation rate.